Focus
L’importanza dei case report in farmacovigilanza
THE IMPORTANCE OF CASE REPORTS IN PHARMACOVIGILANCE
Mauro Venegoni
Già responsabile del Servizio di Farmacovigilanza, Agenzia Italiana del Farmaco (AIFA)
Ottobre 2009 - pagg. 501 -507
LE REAZIONI AVVERSE AI FARMACI IN ETÀ PEDIATRICA
Abstract
The publication of case reports is one of the useful didactic instrument to disseminate the
knowledge on many or very rare adverse reactions that physicians must know whenever
they make prescriptions. Moreover, the activity of pharmacovigilance and the recommendations
that have to follow certain rules are an indispensable collaboration tool by the
physicians for the drug regulatory agencies.
Parole chiave
Suggerite dall'AI
Classificazione MeSH
Bibliografia
1. Sridhar AR, Willett LL, Castiglioni A, et al.
Scholarship opportunities for trainees and clinician
educators: learning outcomes from a
case report writing workshop. J Gen Intern
Med 2009;24:398-401.
2. Avorn J. Paying for drug approvals - who’s using whom? N Engl J Med 2007;356:1697- 700.
3. Kelly WN, Arellano FM, Barnes J, et al. Guidelines for submitting adverse event reports for publication. Pharmacoepidemiol Drug Saf 2007;16:581-7.
2. Avorn J. Paying for drug approvals - who’s using whom? N Engl J Med 2007;356:1697- 700.
3. Kelly WN, Arellano FM, Barnes J, et al. Guidelines for submitting adverse event reports for publication. Pharmacoepidemiol Drug Saf 2007;16:581-7.
Corrispondenza: m.venegoni@aifa.gov.it
